Search research articles
Contact Us
Filters
Showing results (41-50 of 187) with videos related to
Page
of 19
Sort By:
Cancer Medicine
|
December 17, 2016
Responses to romidepsin by line of therapy in patients with relapsed or refractory peripheral T-cell lymphoma
Francine Foss, Barbara Pro, H Miles Prince, et al.
Leukemia & Lymphoma
|
August 28, 2023
Hypereosinophilic syndrome with leptomeningeal involvement: a not-so-classical case report of classical Hodgkin Lymphoma
George Mellgard, Elina Stoffel, Alissa Michel, et al.
Journal of the American Academy of Dermatology
|
February 19, 2008
CD4+ CD56+ hematodermic/plasmacytoid dendritic cell tumor with response to pralatrexate
Justin J Leitenberger, Cindy N Berthelot, Kristel D Polder, et al.
Journal of Hematology & Oncology
|
September 20, 2017
Erratum to: Romidepsin for the treatment of relapsed/refractory peripheral T cell lymphoma: prolonged stable disease provides clinical benefits for patients in the pivotal trial
Francine Foss, Steven Horwitz, Barbara Pro, et al.
Journal of Hematology & Oncology
|
March 12, 2016
Romidepsin for the treatment of relapsed/refractory peripheral T cell lymphoma: prolonged stable disease provides clinical benefits for patients in the pivotal trial
Francine Foss, Steven Horwitz, Barbara Pro, et al.
Cancer Journal (Sudbury, Mass.)
|
September 12, 2003
Importance of esophagogastroduodenoscopy in the evaluation of non-gastrointestinal mucosa-associated lymphoid tissue lymphoma
Bouthaina S Dabaja, Chul S Ha, Richard B Wilder, et al.
Leukemia & Lymphoma
|
October 27, 2006
Phase 2 study of fludarabine and paclitaxel in patients with recurrent low-grade non-Hodgkin's lymphoma
Barbara Pro, Fredrick B Hagemeister, Peter McLaughlin, et al.
Leukemia & Lymphoma
|
January 7, 2006
Pegfilgrastim administered in a single fixed dose is effective in inducing neutrophil count recovery after paclitaxel and topotecan chemotherapy in patients with relapsed aggressive non-Hodgkin's lymphoma
Barbara Pro, Luis Fayad, Peter McLaughlin, et al.
Cancer
|
December 19, 2007
Phase 2 study of gemcitabine in combination with rituximab in patients with recurrent or refractory Hodgkin lymphoma
Yasuhiro Oki, Barbara Pro, Luis E Fayad, et al.
Journal of the American Academy of Dermatology
|
July 6, 2017
CD8<sup>+</sup> mycosis fungoides: A low-grade lymphoproliferative disorder
Maria Estela Martinez-Escala, Robert W Kantor, Ahuva Cices, et al.
Page
of 19
Search research articles
Search
Showing results (41-50 of 187) with videos related to
Sort By:
Page
of 19
Cancer Medicine
|
December 17, 2016
Responses to romidepsin by line of therapy in patients with relapsed or refractory peripheral T-cell lymphoma
Francine Foss, Barbara Pro, H Miles Prince, et al.
Leukemia & Lymphoma
|
August 28, 2023
Hypereosinophilic syndrome with leptomeningeal involvement: a not-so-classical case report of classical Hodgkin Lymphoma
George Mellgard, Elina Stoffel, Alissa Michel, et al.
Journal of the American Academy of Dermatology
|
February 19, 2008
CD4+ CD56+ hematodermic/plasmacytoid dendritic cell tumor with response to pralatrexate
Justin J Leitenberger, Cindy N Berthelot, Kristel D Polder, et al.
Journal of Hematology & Oncology
|
September 20, 2017
Erratum to: Romidepsin for the treatment of relapsed/refractory peripheral T cell lymphoma: prolonged stable disease provides clinical benefits for patients in the pivotal trial
Francine Foss, Steven Horwitz, Barbara Pro, et al.
Journal of Hematology & Oncology
|
March 12, 2016
Romidepsin for the treatment of relapsed/refractory peripheral T cell lymphoma: prolonged stable disease provides clinical benefits for patients in the pivotal trial
Francine Foss, Steven Horwitz, Barbara Pro, et al.
Cancer Journal (Sudbury, Mass.)
|
September 12, 2003
Importance of esophagogastroduodenoscopy in the evaluation of non-gastrointestinal mucosa-associated lymphoid tissue lymphoma
Bouthaina S Dabaja, Chul S Ha, Richard B Wilder, et al.
Leukemia & Lymphoma
|
October 27, 2006
Phase 2 study of fludarabine and paclitaxel in patients with recurrent low-grade non-Hodgkin's lymphoma
Barbara Pro, Fredrick B Hagemeister, Peter McLaughlin, et al.
Leukemia & Lymphoma
|
January 7, 2006
Pegfilgrastim administered in a single fixed dose is effective in inducing neutrophil count recovery after paclitaxel and topotecan chemotherapy in patients with relapsed aggressive non-Hodgkin's lymphoma
Barbara Pro, Luis Fayad, Peter McLaughlin, et al.
Cancer
|
December 19, 2007
Phase 2 study of gemcitabine in combination with rituximab in patients with recurrent or refractory Hodgkin lymphoma
Yasuhiro Oki, Barbara Pro, Luis E Fayad, et al.
Journal of the American Academy of Dermatology
|
July 6, 2017
CD8<sup>+</sup> mycosis fungoides: A low-grade lymphoproliferative disorder
Maria Estela Martinez-Escala, Robert W Kantor, Ahuva Cices, et al.
Page
of 19